168 related articles for article (PubMed ID: 11867808)
21. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
[TBL] [Abstract][Full Text] [Related]
23. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model.
Kuszyk BS; Boitnott JK; Choti MA; Bluemke DA; Sheth S; Magee CA; Horton KM; Eng J; Fishman EK
Radiology; 2000 Nov; 217(2):477-86. PubMed ID: 11058649
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma.
Forsberg F; Goldberg BB; Liu JB; Merton DA; Rawool NM; Shi WT
Radiology; 1999 Jan; 210(1):125-32. PubMed ID: 9885597
[TBL] [Abstract][Full Text] [Related]
25. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
26. Contrast-enhanced transrectal ultrasonography of a novel canine prostate cancer model.
Forsberg F; Johnson DK; Merton DA; Li JB; Losco PE; Hagen EK; Goldberg BB
J Ultrasound Med; 2002 Sep; 21(9):1003-13. PubMed ID: 12216748
[TBL] [Abstract][Full Text] [Related]
27. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
28. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
[TBL] [Abstract][Full Text] [Related]
29. CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model.
Leander P; Månsson S; Ege T; Besjakov J
Acta Radiol; 1996 May; 37(3 Pt 1):242-9. PubMed ID: 8845249
[TBL] [Abstract][Full Text] [Related]
30. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
31. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing.
Bleuzen A; Huang C; Olar M; Tchuenbou J; Tranquart F
Ultraschall Med; 2006 Feb; 27(1):40-8. PubMed ID: 16470478
[TBL] [Abstract][Full Text] [Related]
33. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
34. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
Oudkerk M; van den Heuvel AG; Wielopolski PA; Schmitz PI; Borel Rinkes IH; Wiggers T
Radiology; 1997 May; 203(2):449-56. PubMed ID: 9114103
[TBL] [Abstract][Full Text] [Related]
35. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
[TBL] [Abstract][Full Text] [Related]
37. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
38. Use of magnetite particles as a contrast agent for MR imaging of the liver.
Kawamura Y; Endo K; Watanabe Y; Saga T; Nakai T; Hikita H; Kagawa K; Konishi J
Radiology; 1990 Feb; 174(2):357-60. PubMed ID: 2296645
[TBL] [Abstract][Full Text] [Related]
39. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences.
Kim SH; Choi D; Lim HK; Kim MJ; Jang KM; Kim SH; Lee WJ; Lee J; Jeon YH; Lim JH
Eur J Radiol; 2006 Sep; 59(3):413-23. PubMed ID: 16678373
[TBL] [Abstract][Full Text] [Related]
40. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
